Fraunhofer USA Center for Molecular Biotechnology Release: Funding Awarded for Biological Countermeasure Reagent Development

Published: Sep 07, 2011

NEWARK, Del.--(BUSINESS WIRE)--Fraunhofer Center for Molecular Biotechnology (FhCMB) announced today that it has been awarded $1.5 million from the Defense Threat Reduction Agency to provide the United States government with a sustainable source of reagents for advancing critical research aimed at developing countermeasures to combat potentially devastating biological pathogens. These reagents will also be valuable for surveillance and diagnostic purposes.

Back to news